Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan · Delayed Price · Currency is JPY 2,417.50
+1.50 (0.06%)
Aug 13, 2026, 3:30 PM JST
Ono Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 504,409 | 515,785 | 486,871 | 502,672 | 447,187 | 361,361 |
Revenue Growth | 1.55% | 5.94% | -3.14% | 12.41% | 23.75% | 16.84% |
Gross Profit Gross Profit Growth | 371,028 | 374,069 | 338,921 | 375,546 | 337,125 | 267,850 |
Operating Income Operating Income Growth | 100,895 | 96,894 | 61,792 | 160,295 | 150,045 | 110,815 |
Net Income Net Income Growth | 76,245 | 69,767 | 50,047 | 127,977 | 112,723 | 80,519 |
Earnings Per Share EPS Growth | 162.22 | 148.42 | 106.41 | 266.57 | 230.79 | 162.16 |
EPS Growth | 77.80% | 39.48% | -60.08% | 15.50% | 42.32% | 7.33% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Japan Japan Growth | 260,885 | 287,085 | 295,247 | 308,229 | 288,155 | 241,971 |
Americas Americas Growth | 210,161 | 197,061 | 167,048 | 158,933 | 142,791 | 105,890 |
Asia Asia Growth | 17,619 | 17,719 | 16,343 | 21,926 | 11,625 | 8,895 |
Europe Europe Growth | 14,024 | 12,324 | 7,503 | 13,585 | 4,616 | 4,605 |
Others Others Growth | 1,595 | 1,595 | 729 | - | - | - |
Total Total Growth | 504,284 | 515,784 | 486,870 | 502,673 | 447,187 | 361,361 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 219,622 | 237,106 | 209,046 | 166,141 | 96,155 | 69,172 |
Total Debt Total Debt Growth | 117,100 | 120,935 | 146,678 | 8,862 | 9,168 | 8,802 |
Net Cash (Debt) Net Cash Growth | 102,522 | 116,171 | 62,368 | 157,279 | 86,987 | 60,370 |
Net Cash Growth | 9710.72% | 86.27% | -60.35% | 80.81% | 44.09% | 9.82% |
Net Cash Per Share Net Cash Per Share Growth | 218.17 | 247.19 | 132.76 | 327.64 | 178.12 | 121.58 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 134,501 | 136,821 | 82,459 | 110,660 | 159,610 | 61,829 |
Capital Expenditures CapEx Growth | -5,763 | -6,024 | -5,431 | -4,020 | -5,340 | -5,497 |
Free Cash Flow Free Cash Flow Growth | 128,738 | 130,797 | 77,028 | 106,640 | 154,270 | 56,332 |
Free Cash Flow Growth | 63.20% | 69.80% | -27.77% | -30.87% | 173.86% | -15.87% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 73.56% | 72.52% | 69.61% | 74.71% | 75.39% | 74.12% |
Operating Margin | 20.00% | 18.79% | 12.69% | 31.89% | 33.55% | 30.67% |
Pretax Margin | 20.07% | 17.96% | 12.19% | 32.57% | 32.10% | 29.06% |
Profit Margin | 15.12% | 13.53% | 10.28% | 25.46% | 25.21% | 22.28% |
FCF Margin | 25.52% | 25.36% | 15.82% | 21.21% | 34.50% | 15.59% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 80.000 | 80.000 | 80.000 | 80.000 | 70.000 | 56.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 14.29% | 25.00% | 12.00% |
Dividend Yield | 3.31% | 3.19% | 5.19% | 3.54% | 2.84% | 2.09% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.89 | 16.91 | 15.04 | 9.01 | 11.97 | 18.79 |
Forward PE | 16.40 | 17.31 | 11.12 | 10.24 | 10.81 | 13.49 |
P/FCF Ratio | 8.82 | 9.02 | 9.77 | 10.81 | 8.75 | 26.86 |
PS Ratio | 2.25 | 2.29 | 1.55 | 2.29 | 3.02 | 4.19 |